Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ('Profound” or the 'Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Uterine fibroids—non-cancerous growths in the womb—remain a major reproductive health challenge for women globally, particularly in Africa, where prevalence rates are among the highest in the world.

CMS has approved ASCs as a site of service for transcervical uterine fibroid ablation — a minimally invasive procedure for symptomatic uterine fibroids that can be performed with the Sonata System ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Uterine fibroids—common, often missed and frequently painful growths made of muscle and other tissue inside the uterus—may dramatically raise the risk of heart disease, a new paper finds. In a study ...

New data from a large US population-based cohort study highlighted uterine fibroids as a potential signal of increased long-term risk for atherosclerotic cardiovascular disease, particularly in women ...

TITLE: A Case of Uterine Rupture with Hemorrhage Caused by Torsion of a Pedunculated Uterine Fibroid in Late Pregnancy, with a Review of the Literature ...